Zota Health Care LImited
All news and filings related to Zota Health Care LImited.
View all news & filings- Low impact
Zota Health Care: Trading Window Closed Oct 1, 2026 for Q2 FY27 Results
Zota Health Care Limited will close its trading window from October 01, 2026. This closure is in anticipation of the Unaudited Financial Results for the quarter and half-year ended September 30, 2026. The window will reopen 48 hours after the results are announced.
Read the summary - Medium impact
Zota Health Care AGM: Approves 10% Final Dividend, Director Re-appointments
Zota Health Care's 26th AGM on Sep 28, 2026, approved the FY26 financial statements and a 10% final dividend (Re. 1/share). Key re-appointments included Kamlesh Rajanikant Zota and Moxesh Ketanbhai Zota. Mahaveer Dhariwal was appointed as Independent Director. Related party transactions were also approved.
Read the summary - Medium impact
Zota Health Care Ltd. Updates Shareholders on Tax Deduction for Final Dividend
Zota Health Care announced its Board recommended a 10% final dividend (Re. 1 per share) for FY2025-26. Shareholders must provide documentation by Sept 30, 2026, for tax deduction at source (TDS) calculations. TDS rates vary for resident and non-resident shareholders based on PAN, Aadhaar linkage, and DTAA provisions. Dividend payment is scheduled for on or after Sept 30, 2026.
Read the summary - Medium impact
Zota Health Care Responds to Proxy Advisor on AGM Resolutions
Zota Health Care addressed proxy advisor IiAS's negative voting recommendations for its AGM on September 28, 2026. The company defended the re-appointment of its Managing Director and the remuneration of its Non-Executive Chairman. It also clarified related party transactions, including financial support to subsidiary EHBCL.
Read the summary - Low impact
Zota Health Care: Independent Director Mrs. Varshabahen Mehta Cessation on Sep 9, 2026
Mrs. Varshabahen Gaurang Mehta has ceased to be an Independent Director of Zota Health Care Limited. Her tenure concluded on September 09, 2026, marking her departure from the board upon completion of her second term.
Read the summary - Low impact
Zota Health Care Announces 26th AGM, Record Date, and Final Dividend via Newspaper Ads
Zota Health Care Limited published newspaper ads for its 26th AGM and final dividend on September 6, 2026. Advertisements appeared in "Gujarat Guardian" and "Financial Express". This complies with SEBI LODR Regulations.
Read the summary - Low impact
Zota Health Care Announces 26th AGM on Sep 28, 2026, via VC/OAVM
Zota Health Care Limited will hold its 26th Annual General Meeting (AGM) on September 28, 2026, via Video Conference. The notice was published in Business Standard and Gujarat Guardian on September 4, 2026.
Read the summary - Medium impact
Zota Health Care Board Approves 26th AGM, Appoints New Director, Declares Dividend
Zota Health Care Limited's Board approved the 26th AGM on September 28, 2026. Record date for dividend and e-voting is September 21, 2026. Mr. Mahaveer Dhariwal appointed as Additional Independent Director. Dividend of Re. 1 per equity share (10%) for FY 2025-26 approved.
Read the summary - Low impact
Zota Health Care Sets Record Date for Final Dividend and AGM on Sept 21, 2026
Zota Health Care Limited has fixed September 21, 2026, as the record date for its final dividend and the 26th Annual General Meeting. This date is crucial for determining shareholders eligible for the dividend payout and participation in the AGM.
Read the summary - Medium impact
Zota Health Care Ltd: Board Approves Director's Report, Sets AGM for Sep 28, Declares Dividend
Zota Health Care Limited's Board approved the Director's Report for FY26. The 26th AGM is scheduled for September 28, 2026. A final dividend of 10% (Re. 1/share) for FY26 was declared, with September 21, 2026, as the record date. Mr. Mahaveer Dhariwal was appointed as Additional Independent Director.
Read the summary - Medium impact
Zota Health Care Board Approves 26th AGM, Dividend; Appoints New Director
Zota Health Care's Board approved the 26th AGM on September 28, 2026, and set September 21, 2026, as the record date for a 10% final dividend (Re. 1 per share). Mr. Mahaveer Dhariwal was appointed as an Additional Independent Director. E-voting is from September 25-27, 2026.
Read the summary - Medium impact
Zota Health Care Releases Q1 FY27 Earnings Call Transcript
Zota Health Care Limited released its Q1 FY27 earnings call transcript. The company added 264 Davaindia stores, reaching 2,825 total. Revenue grew 67.6% YoY to ₹17,360 lakhs. Gross margins improved to 61.96%. Management discussed increased marketing spend and strategic investments, aiming for cash breakeven within 3-4 quarters.
Read the summary - Low impact
Zota Health Care Publishes Unaudited Financial Results Newspaper Advertisements
Zota Health Care Limited published newspaper advertisements on August 15, 2026, for its unaudited financial results for the quarter ended June 30, 2026. The ads appeared in Business Standard and Gujarat Guardian, directing investors to webpages for full results.
Read the summary - Low impact
Zota Health Care: Audio Recording Link of Earnings Conference Call for Q1 FY27 Released
Zota Health Care Limited released the audio recording link for their earnings conference call held on August 14, 2026. The call discussed financial results for the quarter ended June 30, 2026.
Read the summary - Low impact
Zota Health Care: Monitoring Agency Report for Q1FY27 QIP Fund Utilization
Zota Health Care Limited's QIP Monitoring Agency Report for Q1FY27 shows ₹34,033.24 lakh in net proceeds. As of June 30, 2026, ₹7,676.24 lakh remained unutilized, primarily invested in fixed deposits. Funds were used for working capital, COCO store expansion via DHML, and general corporate purposes.
Read the summary - Low impact
Zota Health Care Schedules Q1FY27 Earnings Call for August 14
Zota Health Care Limited will announce its Q1FY27 results on August 13, 2026. An Earnings Call is scheduled for August 14, 2026, at 11:30 hrs. IST, to discuss the financial performance. Key management personnel will participate in the call.
Read the summary - Low impact
Zota Health Care: Newspaper Ads for Equity Shares Transfer to IEPF Account
Zota Health Care Limited published newspaper ads on July 25, 2026, regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF) Account, in compliance with SEBI regulations.
Read the summary - Low impact
Zota Health Care Ltd. Issues Corrigendum for FY26 Consolidated Cash Flow Statement
Zota Health Care Limited issued a corrigendum for its FY26 Consolidated Cash Flow Statement due to typographical errors. This correction does not impact other financial statements. The rectified figures are available on the company and NSE websites.
Read the summary - Medium impact
Zota Health Care Acquires 2.35 Lakh Shares in Subsidiary Davaindia Health Mart
Zota Health Care Limited acquired 2,35,512 equity shares in its subsidiary, Davaindia Health Mart Limited, on July 17, 2026. The acquisition, valued at ₹1,195.22 crore, was a conversion of outstanding unsecured loans. Davaindia Health Mart reported FY26 turnover of ₹267.71 crore. This move aims to reduce consolidated debt and improve net worth.
Read the summary - Low impact
Zota Health Care: Certificate under SEBI Reg 74(5) for Q1FY27
Zota Health Care Limited submitted a certificate under SEBI Regulation 74(5) for the quarter ended June 30, 2026. The company's RTA confirmed dematerialization of shares, with securities listed and certificates cancelled.
Read the summary - Medium impact
Zota Health Care: Davaindia Stores Expand by 264 in Q1FY27 to Reach 2825
Zota Health Care Limited expanded its Davaindia store network by opening 264 new stores in Q1FY27. The total number of operative stores reached 2825 as of June 30, 2026, up from 2579 on March 31, 2026. COCO stores increased to 1855 and FOFO stores to 970.
Read the summary - Low impact
Zota Health Care Acquires 20 Lakh Equity Shares in Wholly Owned Subsidiary KMHP Ventures
Zota Health Care Limited acquired 20,00,000 equity shares in its wholly-owned subsidiary, KMHP Ventures Limited, for ₹2 crore. The acquisition was made via a rights issue at ₹10 per share. KMHP plans to launch "Ugo Generic" retail stores for generic medicines.
Read the summary - Medium impact
Zota Health Care Acquires 10 Lakh Shares in Subsidiary Curexis Ventures
Zota Health Care acquired 10,00,000 equity shares in its subsidiary Curexis Ventures for ₹2 crore. The acquisition was made via a rights issue at ₹20 per share. Curexis, involved in drug manufacturing and retail pharmacy, had a turnover of ₹1.18 Lakhs in FY25-26.
Read the summary - Medium impact
Zota Health Care to Acquire 80% Stake in Globotask IT Consultancy for ₹25 Lakhs
Zota Health Care Limited will acquire an 80% stake in Globotask IT Consultancy Services Private Limited for ₹25 Lakhs. This move aims to enhance IT solutions for the company and its subsidiaries. The trading window will be closed from June 19, 2026, until 48 hours post-acquisition announcement.
Read the summary - Medium impact
Zota Health Care to Acquire 80% Stake in Globotask IT Consultancy for ₹25 Lakhs
Zota Health Care Limited will acquire an 80% stake in Globotask IT Consultancy Services Private Limited for ₹25 Lakhs. GITCL will provide IT solutions to Zota. The transaction is not a related party transaction.
Read the summary - Low impact
Zota Health Care: Promoter Group Disclosure for FY Ended March 31, 2026
Zota Health Care Limited filed a disclosure under SEBI Takeover Regulations for the financial year ended March 31, 2026. The filing was made by Promoter & Whole-time Director, Mr. Himanshu Muktilal Zota, on behalf of the Promoter Group and Persons Acting in Concert.
Read the summary - Medium impact
Zota Health Care Q4FY26: Transcript of Earnings Conference Call Released
Zota Health Care released the transcript for its Q4FY26 and FY26 earnings conference call held on May 25, 2026. The company added 997 Davaindia stores in FY26, reaching 2,579 total stores. Davaindia drove 77% of FY26 revenue. A INR 350 crore QIP was completed. Management aims for 5,000+ Davaindia stores by FY29.
Read the summary - Low impact
Zota Health Care to Attend Axis Capital's Rising Stars Conference on June 2, 2026
Zota Health Care Limited will attend Axis Capital's Rising Stars Conference on June 2, 2026, in Mumbai. The company will use publicly available information for business updates during one-on-one and group meetings with analysts and institutional investors.
Read the summary - Low impact
Zota Health Care Limited Releases Earnings Conference Call Audio Recording
Zota Health Care Limited has released the audio recording of its earnings conference call. The call, held on May 25, 2026, discussed the company's financial and operational performance for the fourth quarter and fiscal year ended March 31, 2026.
Read the summary - Low impact
Zota Health Care Ltd. Publishes Audited Financial Results for Q4FY26
Zota Health Care Limited published its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The advertisements appeared on May 24, 2026, in "Financial Express" and "Gujarat Guardian".
Read the summary - Low impact
Zota Health Care to attend Ashika Institutional Equities Investor Conference on May 27, 2026
Zota Health Care Limited will attend the Ashika Institutional Equities Investor Conference on May 27, 2026, at the Taj Hotel, Santacruz, Mumbai. The meetings will consist of one-on-one and/or group sessions, utilizing publicly available business update presentations. No unpublished price-sensitive information will be disclosed during the event.
Read the summary - High impact
Zota Health Care FY26 Revenue Up 84% YoY to ₹538.66 Crore; Davaindia Business Grows to ₹417.41 Crore
Zota Health Care's FY26 revenue rose 84% YoY to ₹538.66 Crore, driven by Davaindia's growth to ₹417.41 Crore. Davaindia expanded to 2,579 stores (1,656 COCO, 923 FOFO). The company acquired 100% stake in Curexis and has appointed Suniel Shetty and M.S. Dhoni as brand ambassadors. The company aims to reach 5,000+ Davaindia stores by FY29.
Read the summary - High impact
Zota Health Care FY26 Revenue Soars 83.86% to ₹53,865.75 Lakhs; Davaindia Stores Reach 2,579
Zota Health Care reported FY26 consolidated revenue growth of 83.86% to ₹53,865.75 lakhs and a 108.57% increase in Gross Profit to ₹32,468.90 lakhs. The Davaindia network expanded to 2,579 stores. The company launched 'All Day Stores' and appointed Akshay Kumar as brand ambassador.
Read the summary - Low impact
Zota Health Care to cap director remuneration at ₹12 crore annually until FY30
Zota Health Care's Promoter Directors will cap their cumulative annual remuneration at ₹12 crore until FY30. This move aims to improve corporate governance and capital allocation for company growth. The decision was voluntarily made by the Chairman, Managing Director, and Whole-time Directors.
Read the summary - Low impact
Zota Health Care: No Deviation in Preferential Issue Funds for Q4FY26
Zota Health Care Limited reported no deviation in the utilization of funds from preferential issues and QIP for the quarter ended March 31, 2026. The Audit Committee reviewed the statement on May 22, 2026, confirming full utilization against original objectives. Funds were raised through multiple preferential issues and a QIP between August 2024 and February 2026.
Read the summary - Medium impact
Zota Health Care Approves Audited FY26 Results, Recommends 10% Dividend, Acquires Subsidiary Stake
Zota Health Care approved audited standalone and consolidated financial results for FY26 ending March 31, 2026. The board recommended a 10% final dividend (Re. 1 per share). The company also approved acquiring a stake in its subsidiary, Davaindia Health Mart Limited, via rights issue.
Read the summary - Medium impact
Zota Health Care Ltd. recommends 10% final dividend, approves financial results.
Zota Health Care Limited's Board approved standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. They recommended a final dividend of 10% (Re. 1 per share) for FY26. The company also approved acquiring shares in its subsidiary, Davaindia Health Mart Limited.
Read the summary - Medium impact
Zota Health Care approves FY26 Audited Results & 10% final dividend
Zota Health Care approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board recommended a 10% final dividend (Re. 1 per share). The company also approved acquiring shares in its subsidiary, Davaindia Health Mart Limited.
Read the summary - Low impact
Zota Health Care to Host Q4FY26 Earnings Call on May 25
Zota Health Care Limited will announce its Q4FY26 and full-year financial results on May 22, 2026. An earnings conference call is scheduled for May 25, 2026, at 15:30 hrs IST, featuring key management personnel.
Read the summary - Medium impact
Zota Health Care Appoints Akshay Kumar as Brand Ambassador, Expands UGO Generic
Zota Health Care Ltd. has appointed Mr. Akshay Kumar as the brand ambassador for the company and its brand “UGO Generic”. The company aims to offer high-quality generic medicines pan India through its stores and approximately 12.5 lakhs retail pharmacies. Mr. Ketankumar Zota, Chairman, expressed confidence that this collaboration will enhance the company's brand presence.
Read the summary - Low impact
Zota Health Care: CRISIL Monitoring Report for Preferential Issue Funds (Q4FY26)
Zota Health Care Limited submitted its Monitoring Agency Report for Q4FY26, confirming full utilization of ₹123.41 crore raised via Preferential Issue. Funds were used for DAVAINDIA project expansion, working capital, and general corporate purposes. Related party transactions for inventory purchase were conducted.
Read the summary - Low impact
Zota Health Care: Monitoring Agency Report for Q4FY26 Preferential Issue Funds Utilization
Zota Health Care Limited filed its Monitoring Agency Report for Q4FY26, confirming utilization of funds from its ₹179.07 crore Preferential Issue. CRISIL Ratings Limited reported that funds were utilized for the 'DAVAINDIA' project expansion, working capital, and GCP, with no material deviations. The report marks the final monitoring of the issue proceeds.
Read the summary - Medium impact
Zota Health Care Limited: Shareholders Approve Special Resolution via Postal Ballot
Zota Health Care Limited shareholders approved a special resolution authorizing the Board to give loans, guarantees, or security, and acquire securities in excess of Section 186 limits. The resolution passed with 13,962,666 votes in favor out of 14,253,510 total votes polled via e-voting. The aggregate limit for these actions is set at ₹1000 crore.
Read the summary - Low impact
Zota Health Care: Certificate under SEBI Reg. 74(5) for Q4FY26
Zota Health Care Limited filed a certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The RTA confirmed dematerialization of shares, with certificates cancelled and depository names updated in records.
Read the summary - Medium impact
Zota Health Care Responds to Proxy Advisory Firm on Loan/Investment Limit Increase
Zota Health Care responded to IiAS regarding a postal ballot to increase the board's authorization for loans, guarantees, and investments from ₹500 crore to ₹1,000 crore. This increase is for future business expansion, strategic acquisitions, and supporting subsidiaries, including Davaindia Health Mart Limited.
Read the summary - Low impact
Zota Health Care Clarifies Financial Reporting Errors, Submits Corrected Statements
Zota Health Care Limited provided clarification on its financial results for September 30, 2025. The company corrected an error in comparative data in the balance sheet and ensured submission in a machine-readable format. Financial figures remain unchanged.
Read the summary - Low impact
Zota Health Care: Davaindia Store Count Expands by 248 in Q4FY26
Zota Health Care Limited opened 248 new Davaindia stores in Q4FY26. The total store count reached 2579 as of March 31, 2026, comprising 1656 COCO and 923 FOFO stores. A total of 997 stores were opened during FY26.
Read the summary - Low impact
Zota Health Care Limited Announces Retirement of Senior Management Personnel
Mr. Ratilal Harkhani, Plant Manager and Senior Management Personnel at Zota Health Care Limited, will retire on March 31, 2026. This change is due to the company's superannuation policy.
Read the summary - Low impact
Zota Health Care: Trading Window Closed April 1st for FY26 Audited Results
Zota Health Care Limited will close its trading window from April 1, 2026. This closure is in anticipation of the announcement of audited financial results for the quarter and year ended March 31, 2026. The window will reopen 48 hours after the results are declared.
Read the summary - Low impact
Zota Health Care Publishes Newspaper Advertisement for Postal Ballot Notice
Zota Health Care Limited published newspaper advertisements on March 17, 2026, for its Postal Ballot Notice. The ads appeared in the Financial Express (English) and Gujarat Guardian (Gujarati). This filing is in compliance with SEBI LODR Regulations.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio